Unexpected Outcomes of Measuring Decision Regret: Using a Breast Cancer Decision-Making Case Example

Author(s):  
Kelly Oman ◽  
Marie-Anne Durand ◽  
Glyn Elwyn ◽  
Renata West Yen ◽  
Christine Marx ◽  
...  
2021 ◽  
Author(s):  
Yan Wang ◽  
Qingyue Zhang ◽  
Jianmei Pang ◽  
Liyuan Shi ◽  
Xiaoyuan Wang ◽  
...  

Abstract Objective: Different surgical methods have different risks and benefits. The Chinese breast cancer(BC) patients’ decision-making of surgical treatment become a critical research question. Patients are often offered several options before surgery, and decision preparation play an important role in decision process. However some patients regret the original decision afterward. To understand the current situation, this study explore mainly explores the status of decision regret among newly diagnosed BC patients,and tests the relationship between decision conflicts, decision-making preparation, and decision regrets. Methods: A cross-sectional survey was conducted. Totally 320 postoperative BC patients were studied using a self-made general data scale, Decision Regret Scale, Decision Conflict Scale, and Preparation for Decision Making Scale. Basic descriptive analyses, Pearson’s correlation analyses and regression analyses were performed. Results: The average score of decision regret among BC patients after surgery was 34.28. Decision regret was positively associated with decision conflict (r=0.853, p<0.01), and negatively associated decision preparation (r=-0.404, p<0.01). Decision-making preparation plays a regulatory role for the emergence of decision conflicts and regrets. The correlation between decision conflicts and decision regrets increases with the increase of decision-making preparation. Conclusion: The adverse effects of decision conflicts on decision regrets gradually increase with the increase of decision-making preparation. Results indicate that reducing decision preparation can be expected to improve the level of decision regret among Chinese BC patients.Thus, Clinical staffs should encourage patients to actively participate in decision-making, provide specialized information support, and improve the level of decision regret among Chinese BCpatients after surgery.


2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 6023-6023
Author(s):  
Sarah T. Hawley ◽  
Nancy K. Janz ◽  
Sarah E Lillie ◽  
Kendra L. Schwartz ◽  
John Graff ◽  
...  

6023 Background: Incorporating partners into treatment decision making is an important element of patient-centered care, yet little is known about the role of partners in the decision process. Methods: We surveyed 503 partners of a population-based sample of breast cancer survivor 4 years after diagnosis (RR= 76%, N=382).The outcome was partners’ reports of decision regret. Independent variables included decision making process measures (partners’ reports of sufficient treatment information receipt and sufficient involvement in decision making), race/ethnicity, age, education and income. Multivariable logistic regression was used to assess associations between decision regret and race/ethnicity, controlling for other variables. Results: 49% of partners were white, 14% African American, 15% more-acculturated Latino, and 18% less-acculturated Latino. One quarter (26%) of partners reported that they received insufficient information and one third (35%) desired more involvement in decision-making. Compared to whites, less-acculturated Latino partners more often reported that they received insufficient information (41% vs. 18%, p<0.05) and desired more involvement in decision-making (49% vs. 14%, p<0.001). Overall 30% of partners reported high decision regret. Multivariate analyses showed factors associated with high decision regret were less-acculturated Latinos, insufficient information receipt and desire for more involvement (Table). Conclusions: Most partners of breast cancer survivors reported low decision regret and positively appraised their involvement in the decision process. Less acculturated Latinos reported more dissatisfaction with the decision process. Findings suggest the need for culturally appropriate treatment decision support interventions that include partners. [Table: see text]


2021 ◽  
Author(s):  
Yan Wang ◽  
Qingyue Zhang ◽  
Jianmei Pang ◽  
Liyuan Shi ◽  
Xiaoyuan Wang ◽  
...  

Abstract Objective: Different surgical methods have different risks and benefits.Chinese breast cancer(BC) patients’ decision-making of surgical treatment becomes a critical research question. Patients are often offered several options before surgery, and decision preparation plays an important role in the decision process. However some patients regret the original decision afterward. To understand the current situation, this study explore mainly explores the status of decision regret among postoperative breast cancer patients,and tests the relationship between decision conflicts, decision-making preparation, and decision regret. Methods: A cross-sectional survey was carried out. Totally 320 postoperative BC patients were studied using a self-made general data scale, Decision Regret Scale, Decision Conflict Scale, and Preparation for Decision Making Scale. Basic descriptive analyses, Pearson’s correlation analyses and regression analyses were performed. Results: The average score of decision regret among BC patients after surgery was 34.28. Decision regret was positively associated with decision conflict (r=0.853, p<0.01), and negatively associated decision preparation (r=-0.404, p<0.01). Decision-making preparation plays a regulatory role for the emergence of decision conflicts and regrets. The correlation between decision conflicts and decision regret increases with the increase in decision-making preparation. Conclusion: The adverse effects of decision conflicts on decision regret gradually increase with the increase in decision-making preparation. Results indicate that reducing decision preparation can be expected to improve the level of decision regret among Chinese postoperative BC patients.Thus, Clinical staffs should encourage patients to take an active part in decision-making, provide specialized information support, and improve the level of decision regret among Chinese BC patients after surgery.


2007 ◽  
Author(s):  
Mary A. O'Brien ◽  
Timothy Whelan ◽  
Amiram Gafni ◽  
Cathy Charles ◽  
Peter Ellis

2020 ◽  
Vol 27 (17) ◽  
pp. 2826-2839 ◽  
Author(s):  
Roberta Caputo ◽  
Daniela Cianniello ◽  
Antonio Giordano ◽  
Michela Piezzo ◽  
Maria Riemma ◽  
...  

The addition of adjuvant chemotherapy to hormonal therapy is often considered questionable in patients with estrogen receptor-positive early breast cancer. Low risk of disease relapse after endocrine treatment alone and/or a low sensitivity to chemotherapy are reasons behind not all patients benefit from chemotherapy. Most of the patients could be exposed to unnecessary treatment- related adverse events and health care costs when treatment decision-making is based only on classical clinical histological features. Gene expression profile has been developed to refine physician’s decision-making process and to tailor personalized treatment to patients. In particular, these tests are designed to spare patients the side effects of unnecessary treatment, and ensure that adjuvant chemotherapy is correctly recommended to patients with early breast cancer. In this review, we will discuss the main diagnostic tests and their potential clinical applications (Oncotype DX, MammaPrint, PAM50/Prosigna, EndoPredict, MapQuant Dx, IHC4, and Theros-Breast Cancer Gene Expression Ratio Assay).


Author(s):  
Marta Maes-Carballo ◽  
Manuel Martín-Díaz ◽  
Luciano Mignini ◽  
Khalid Saeed Khan ◽  
Rubén Trigueros ◽  
...  

Objectives: To assess shared decision-making (SDM) knowledge, attitude and application among health professionals involved in breast cancer (BC) treatment. Materials and Methods: A cross-sectional study based on an online questionnaire, sent by several professional societies to health professionals involved in BC management. There were 26 questions which combined demographic and professional data with some items measured on a Likert-type scale. Results: The participation (459/541; 84.84%) and completion (443/459; 96.51%) rates were high. Participants strongly agreed or agreed in 69.57% (16/23) of their responses. The majority stated that they knew of SDM (mean 4.43 (4.36–4.55)) and were in favour of its implementation (mean 4.58 (4.51–4.64)). They highlighted that SDM practice was not adequate due to lack of resources (3.46 (3.37–3.55)) and agreed on policies that improved its implementation (3.96 (3.88–4.04)). The main advantage of SDM for participants was patient satisfaction (38%), and the main disadvantage was the patients’ paucity of knowledge to understand their disease (24%). The main obstacle indicated was the lack of time and resources (40%). Conclusions: New policies must be designed for adequate training of professionals in integrating SDM in clinical practice, preparing them to use SDM with adequate resources and time provided.


Sign in / Sign up

Export Citation Format

Share Document